Research Article
[Retracted] Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Carcinoma: A Real-World Study
Figure 8
DFS curves of luminal B/HER2+ and nonluminal B/HER2+ patients in non-pCR patients without trastuzumab use.